Phosphorus-32 - Wikipedia
Phosphorus-32 (32 P) is a radioactive isotope of phosphorus. The nucleus of phosphorus-32 contains 15 protons and 17 neutrons, one more neutron than the most common isotope of phosphorus, phosphorus-31. Phosphorus-32 only exists in small quantities on Earth as it has a short half-life of 14 days and so decays rapidly.
Phosphorus-32 - isotopic data and properties - ChemLin
Phosphorus-32 is a radioisotope of the chemical element phosphorus, which has 17 neutrons in the atomic nucleus in addition to the element-specific 15 protons, resulting in a mass number of 32. See also: list of Phosphorus isotopes.
Phosphorus-32 is an energetic beta emitter which can penetrate up to 0.8 cm into living skin tissue. Therefore, this isotope poses an external (skin) dose hazard to persons as well as a potential internal hazard.
Phosphorus-32 | H3P | CID 26751 - PubChem
2021年10月14日 · There is sufficient evidence in humans that therapeutic ingestion or injection of phosphorus-32 administered as inorganic phosphate causes acute leukemia.
Isotopes of phosphorus - Wikipedia
32 P is a radioactive isotope of phosphorus with relative atomic mass 31.973907 and half-life of 14.26 days. 32 P is a radioactive isotope of phosphorus with beta particle-emitting radiocytotoxic activity.
Phosphorous-32 is used extensively in life sciences research. It is easily detected and measured, available in a wide variety of radiochemicals, and relatively inexpensive.
Phosphorus-32 | Office of Environmental Health and Safety
Emissions: Beta particles with a maximum energy of 1.71 MeV and an average energy of 0.7 MeV. Shielding: 3/8” plexiglas/lucite will shield all P-32 betas. For high activity sources exceeding a few millicuries, it may be desirable to add lead shielding outside the plexiglas shielding to shield against bremsstrahlung x-rays.
Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth …
Aqueous 32 P [PO 4] is a pure beta-emitter that has been used for several decades to treat non-malignant human myeloproliferative diseases. 32 P [PO 4] was directly compared to a more powerful pure beta-emitter, the clinically important 90 Y isotope.
Phosphorus-32, a Clinically Available Drug, Inhibits Cancer ... - PLOS
2015年6月1日 · Aqueous 32 P [PO 4] is a pure beta-emitter that has been used for several decades to treat non-malignant human myeloproliferative diseases. 32 P [PO 4] was directly compared to a more powerful pure beta-emitter, the clinically important 90 Y isotope.
Phosphorus-32, a clinically available drug, inhibits cancer
2015年6月1日 · Aqueous 32P [PO4] is a pure beta-emitter that has been used for several decades to treat non-malignant human myeloproliferative diseases. 32P [PO4] was directly compared to a more powerful pure beta-emitter, the clinically important 90Y isotope.